Login / Signup

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.

Lhanoo GunawardhanaMichael A BeckerAndrew WheltonBarbara HuntMajin CastilloKenneth Saag
Published in: Arthritis research & therapy (2018)
ClinicalTrials.gov, NCT02128490 Registered on 29 April 2014.
Keyphrases
  • phase ii
  • clinical trial
  • double blind
  • open label
  • placebo controlled
  • phase iii
  • high intensity
  • uric acid
  • randomized controlled trial